Blue Capital Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.45M Sell
2,980
-127
-4% -$150K 2.15% 7
2026
Q2
$3.73M Sell
3,107
-511
-14% -$522K 2.37% 5
2026
Q1
$3.33M Buy
3,618
+109
+3% +$111K 2.17% 10
2025
Q4
$3.77M Buy
3,509
+4
+0.1% +$3.82K 2.69% 7
2025
Q3
$2.67M Sell
3,505
-374
-10% -$278K 1.99% 14
2025
Q2
$3.02M Buy
+3,879
New +$3.01M 2.14% 11
2024
Q4
$3.09M Buy
+4,000
New +$3.31M 2.18% 16

Other funds holding LLY

Blue Capital Inc's LLY Position: Q3 2026 in Review

Blue Capital Inc reduced its Eli Lilly (LLY) stake by 4.1% in Q3 2026, selling an estimated $150K and leaving 2,980 shares worth $3.45M. The position accounts for 2.15% of the portfolio, ranked #7.

Blue Capital Inc first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.77M in Q4 2025. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Blue Capital Inc held 2,980 shares of Eli Lilly worth $3.45M as of Q3 2026.
  • Blue Capital Inc sold 127 Eli Lilly shares in Q3 2026, an estimated $150K.
  • Eli Lilly made up 2.15% of Blue Capital Inc's portfolio in Q3 2026, its #7 holding.
  • Blue Capital Inc first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Blue Capital Inc's Eli Lilly position peaked at $3.77M in Q4 2025.
  • 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Blue Capital Inc's 13F filing for Q3 2026, filed 13 Oct 2026.